Scholars@Duke
Courtney Page

Courtney Page

Biostatistician III
Duke Clinical Research Institute
courtney.page@duke.edu
200 Moriss St, Location #5600-B, Durham, NC 27701
P.O. Box 17969, Durham, NC 27715

Scholarly Works - Conferences

Real-world early quality of life (QOL) changes on IO-based regimens in the prospective observational ODYSSEY metastatic renal cell carcinoma (mRCC) study.

Conference Journal of Clinical Oncology · March 1, 2026 Lack of standardized reporting and collection of patient-reported outcomes (PROs) limits cross-trial comparisons of first-line IO-based regimens for mRCC. Prospectively collected real world data may fill this important knowledge gap. Pts with stable/improv ... Full text Cite

Preliminary analysis of baseline characteristics, patient reported outcomes (PROs), and treatment selection in ODYSSEY

Conference Journal of Clinical Oncology · January 1, 2024 Background: Tyrosine kinase inhibitors (TKI) and immuno-oncology (IO) agents alone or in combination have revolutionized the landscape of management for untreated metastatic renal cell carcinoma (mRCC). Baseline quality of life (QOL) outside of interventio ... Full text Cite